Top Medical News from Across Medscape

  • Artificial Sweeteners Alter Gut Response to GlucoseLarge amounts of artificial sweeteners interfere with the gut's response to glucose, increasing both glucose absorption and glycemic response and inhibiting production of GLP-1.
  • 'Food as Medicine' Feasible in Pilot Heart-Failure TrialPilot results of the GOURMET-HF trial show patients discharged after HF hospitalization receiving prepared, DASH-compatible meals had no improvement in quality of life, the primary end point, but there was a trend to reduced rehospitalization.
  • High, Low Magnesium Levels Linked to Dementia RiskFindings that both low and high levels of serum magnesium were associated with increased risk for all-cause dementia suggest a U-shaped relationship, note investigators.
  • FDA OKs First Duodenoscope With Disposable CapThe agency said that the single-use disposable cap will make it easier to decontaminate the scope to reduce the threat of spreading deadly antibiotic-resistant infections.

Special Report

  • Healthcare policy is the number one topic -- not just in Washington, DC but in hospitals, medical practices, and homes. With so much happening on so many fronts, it's hard to keep up. Let us do it for you.

Business of Medicine

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California